Stevanato Group S.p.A. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Cover
- Cover Page
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant accounting policies (Policies)
- Changes in Accounting Policies and Disclosures (Policies)
Notes Tables
Notes Details

Financial assets - investments FVTPL

Financial assets - investments FVTPL	12 Months Ended
Dec. 31, 2022
Disclosure of financial assets [abstract]
Financial assets - investments FVTPL	19. Financial assets - investments FVTPL Financial assets amount to EUR 782 thousand at December 31, 2022 (EUR 1,084 thousand at December 31, 2021), primarily include the investment in Rani Therapeutics Holdings INC, which is measured at fair value through profit or loss and amounts to EUR 443 thousand at December 31, 2022 (EUR 1,024 thousand at December 31, 2021). Additional disclosures on fair value measurement has been included on Note 29.

Financial assets - investments FVTPL

12 Months Ended

Dec. 31, 2022

Disclosure of financial assets [abstract]

Financial assets - investments FVTPL

19. Financial assets - investments FVTPL

Financial assets amount to EUR 782 thousand at December 31, 2022 (EUR 1,084 thousand at December 31, 2021), primarily include the investment in Rani Therapeutics Holdings INC, which is measured at fair value through profit or loss and amounts to EUR 443 thousand at December 31, 2022 (EUR 1,024 thousand at December 31, 2021). Additional disclosures on fair value measurement has been included on Note 29.